• Sign In
  • Sign Up
    Loading ...
View All Updates Mark All Read
THE FREE WORLD PRESS ~ Paul Coulbeck, Chatham-Kent--Leamington Marijuana Party
  • Home
  • Members
  • Albums
  • Classifieds
  • Blogs
  • Polls
  • Forum
  • Chat
  • Groups
  • Events
  • Videos
  • Music

Member Info

  • Profile Type: Regular Member
  • Profile Views: 631 views
  • Friends: 0 friends
  • Last Update: August 24, 2023
  • Joined: August 24, 2023
  • Updates
  • Info
  • Blogs(1)

Updates

The post was not added to the feed. Please check your privacy settings.
  • Scarlett Zou
    Scarlett Zou wrote a new blog entry:
    Research And Development of Infectious Disease Vaccines
    Research And Development of Infectious Disease Vaccines
    As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such...
    • August 24, 2023
  • Scarlett Zou
    Scarlett Zou has just signed up. Say hello!
    • August 24, 2023
View More
Loading ...

Info

Personal Information

  • First Name Scarlett
  • Last Name Zou
  • Gender Female
  • Birthday June 6, 1992

Contact Information

  • Website http://www.biochempeg.com/
  • Twitter https://twitter.com/biochempeg
  • Facebook https://www.facebook.com/htpbiochempeg

Personal Details

  • About Me Biopharma PEG Scientific Inc. is a biotechnology-oriented company in Watertown, Massachusetts. We are dedicated to manufacturing and supplying high purity monodispersed and polydispersed polyethylene glycol (PEG) derivatives and PEG raw material, PEGylation services, and custom PEG derivative synthesis to clients worldwide. We continuously expand the capability to provide large-scale manufacture of high purity PEG derivatives with an extensive variety of functional groups, in both non-GMP and GMP grade.

Blogs

  • Research And Development of Infectious Disease Vaccines

    Posted August 24, 2023

    As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant...

View All Entries
Copyright ©2024  -  Privacy  -  Terms of Service  -  Contact  -  Mobile Site

Create Account

You will use your email address to login.

 
 

Member Sign In

If you already have an account, please enter your details below. If you don't have one yet, please sign up first.

 
 
 
Forgot Password?
Share